TABLE 2.
Patient demographics and characteristics for 84 papillomas surgically excised following core needle biopsy according to presence or absence of upgraded pathology
| Variable | Pathology upgradeda (n = 20) | Pathology not upgraded (n = 64) | p |
|---|---|---|---|
| Patient age (year) | |||
| Premenopausal (<52) | 4 (19) | 28 (44) | 0.11 |
| Postmenopausal (≥52) | 16 (80) | 36 (56) | |
| Race | |||
| Caucasian | 13 (62) | 35 (55) | 0.92 |
| African American | 6 (30) | 24 (38) | |
| Other | 1 (5) | 5 (8) | |
| Biopsy technique | |||
| Stereotactic, vacuum-assisted | 6 (29) | 16 (25) | 0.99 |
| Ultrasound-guided | 14 (70) | 44 (69) | |
| Other | 0 | 4 (6) | |
| Mammographic appearance | |||
| Calcifications | 5 (24) | 11 (17) | 0.33 |
| Mass/density/asymmetry | 9 (45) | 33 (52) | |
| Not visible | 6 (29) | 20 (31) | |
| Palpability | |||
| Palpable | 6 (29) | 15 (23) | 0.77 |
| Not palpable | 14 (70) | 49 (77) | |
| Location | |||
| Central | 5 (24) | 10 (16) | 0.51 |
| Peripheral | 15 (71) | 53 (83) | |
| Other | 1 (5) | 1 (2) | |
| Nipple discharge | |||
| Present | 2 (10) | 3 (5) | 0.25 |
| Absent | 18 (90) | 61 (95) | |
| Prior cancer history | |||
| Prior cancer | 1 (5) | 4 (6) | 0.99 |
| No prior cancer | 19 (95) | 60 (94) | |
| Concurrent cancer | |||
| Concurrent cancer | 3 (15) | 9 (14) | 0.99 |
| No concurrent cancer | 17 (85) | 55 (86) |
Data are numbers with percentages in parentheses unless otherwise indicated
a
For two of these lesions, pathology was upgraded at excisions performed 2 years after the needle core biopsy